Literature DB >> 3214275

Analysis of the mechanism of influenza B virus inactivation by guinea pig serum.

F Yamamoto Goshima1, K Maeno, S Shibata, H Mano, T Suzuki, Y Nishi.   

Abstract

Normal guinea pig serum lacking detectable antiviral antibody inactivated influenza B virus via the classical complement pathway. This virus inactivation appeared to result from the steric hindrance of HA activity by the association with the virus of serum proteins presumed to be complement components. Trypsin digestion of the associated proteins fully restored the HA activity but not infectivity. It was found that the virus underwent minor disruption of the envelope and degradation of M1 protein and genomic RNA.

Entities:  

Mesh：

Substances：

Year:  1988        PMID： 3214275     DOI： 10.1007/bf01311099

Source DB:  PubMed          Journal:  Arch Virol        ISSN： 0304-8608            Impact factor:   2.574


  8 in total

1.  Antibody-complement interactions with purified lymphocytic choriomeningitis virus.

Authors:  R M Welsh; P W Lampert; P A Burner; M B Oldstone
Journal:  Virology       Date:  1976-08       Impact factor: 3.616

2.  Formation and biologic role of polyoma virus-antibody complexes. A critical role for complement.

Authors:  M B Oldstone; N R Cooper; D L Larson
Journal:  J Exp Med       Date:  1974-08-01       Impact factor: 14.307

3.  Developmental sequence and intracellular sites of synthesis of three structural protein antigens of influenza A2 virus.

Authors:  K Maeno; E D Kilbourne
Journal:  J Virol       Date:  1970-02       Impact factor: 5.103

4.  Neutralization of influenza virus by normal human sera: mechanisms involving antibody and complement.

Authors:  D P Beebe; R D Schreiber; N R Cooper
Journal:  J Immunol       Date:  1983-03       Impact factor: 5.422

5.  Plaque formation by influenza B virus in a porcine kidney cell line.

Authors:  M Shibata; K Maeno; S Isomura; T Tsurumi; H Aoki; S Suzuki
Journal:  Microbiol Immunol       Date:  1982       Impact factor: 1.955

6.  Mechanism of interference between influenza A/WSN and B/Kanagawa viruses.

Authors:  H Aoki; Y Nishiyama; T Tsurumi; M Shibata; Y Ito; H Seo; S Yoshii; K Maeno
Journal:  J Gen Virol       Date:  1984-08       Impact factor: 3.891

7.  Inactivation of influenza B virus by normal guinea-pig serum.

Authors:  F Yamamoto; K Maeno; S Shibata; M Iinuma; A Miyama; Y Kawamoto
Journal:  J Gen Virol       Date:  1987-04       Impact factor: 3.891

8.  Lysis of RNA tumor viruses by human serum: direct antibody-independent triggering of the classical complement pathway.

Authors:  N R Cooper; F C Jensen; R M Welsh; M B Oldstone
Journal:  J Exp Med       Date:  1976-10-01       Impact factor: 14.307
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.